SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (252)7/7/2003 4:40:11 AM
From: nigel bates  Respond to of 590
 
>>ABGX plus their cash might make for an interesting pipe.>>
Cash shouldn't be a major consideration at Amgen.

Of course not. I should have written 'ABGX plus the AMGN cash'. There is a lot of interesting stuff that might happen much faster given the AMGN resources.

OTOH, as a shareholder, I agree with Miljenko. A takeout at (say) 50% premium to the present price isn't why I'm holding ABGX.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News